EP2474521
Mjög hrein 2-[4-(3- og 2-flúorbensýloxý)bensýlamínó]própanamíð til notkunar sem lyf og lyfjablöndur sem innihalda þau
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.6.2007EP published:
10.8.2016EP application number:
12163085.9
EP translation filed:
21.10.2016Grant published:
15.11.2016EPO information:
European Patent Register
Max expiry date:
7.6.2027Expiry date:
7.6.2026Next due date:
30.6.2026
Title:
High purity degree 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides for use as medicaments and pharmaceutical formulations containing them
Timeline
Today
8.6.2007EP application
10.8.2016EP Publication
21.10.2016Translation submitted
15.11.2016Registration published
7.6.2026Expires
Owner
Name:
Newron Pharmaceuticals S.p.A.Address:
Via L. Ariosto, 21, 20091, Bresso (MI), IT
Inventor
Name:
Barbanti, ElenaAddress:
COLOGNO MONZESE (MI), IT
Name:
Caccia, CarlaAddress:
GALLARATE (VA), IT
Name:
Salvati, PatriciaAddress:
ARESE (MI), IT
Name:
Velardi, FrancescoAddress:
CAMERI (MO), IT
Name:
Ruffilli, TizianoAddress:
VIGLIANO BIELLESE (BI), IT
Name:
Bogogna, LuigiAddress:
VAPRIO D'AGOGNA (NO), IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
06012565Date:
19.6.2006Country:
EP
Classification
Categories:
C07C 231/10, C07C 233/13, A61K 31/165, C07C 231/12, C07C 231/18
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 17.5.2017
Expires: 7.6.2018
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.5.2018
Expires: 7.6.2019
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 20.5.2019
Expires: 7.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 19.5.2020
Expires: 7.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 18.5.2021
Expires: 7.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 18.5.2022
Expires: 7.6.2023
Payer: Patice ehf.
Number: 17
Paid: 24.5.2023
Expires: 7.6.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 21.5.2024
Expires: 7.6.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 2.6.2025
Expires: 7.6.2026
Payer: Árnason Faktor ehf.